London, England -- (SBWIRE) -- 05/07/2012 -- Botox will continue its reign as a bestseller in US beauty clinics due to competitive pricing and reductions in side effects, according to a new report by medical intelligence company GlobalData.

The new report* states that facial aesthetics represent a popular cosmetic treatment, as they offer long-term results at competitive prices without any need for surgical procedures. Botox in particular is predicted to maintain its lead in terms of market share during future years, due to increased patient comfort, short procedure times and immediate results.

Botox can be used to treat chronic wrinkles of the forehead, eyelids, lips and neck, and is the most effective non-surgical anti-wrinkle solution available today, working in just five to 10 minutes. The ingredients used in botox degrade within six months, which means that both the results from treatment, as well as any adverse side effects, are temporary. This acts to lower the risks of treatment and improve the rate of income for practitioners – especially in the US, which accounts for 40% of the botox market. High levels of competition in the future market will result in decreasing price trends in the US, encouraging further popularity.

The dermal fillers market will grow in the future due to the increasing consumer preference for hyaluronic acid-based dermal fillers (HA fillers), which offer fewer side effects in exchange for results lasting just three to six months. This may be good news for aesthetic centers, as HA fillers will provide recurring income.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/ReportStore/RequestSamplePages.aspx?ID=Facial-Aesthetics-%28Botulinum-Toxin-Dermal-Fillers%29-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2018&companyID=sbwire

In contrast, the Particle and Polymer Fillers (PPF) market is expected to struggle, as the longevity of aesthetic results lasting up to two years is countered by a higher side effects profile. Collagen products will continue to experience their historic decline in sales, due to increasing awareness of other options such as botox and HA fillers.

Currently, no facial aesthetic procedure can offer permanency, and the longevity of results correlates with higher medical risks. Long-term market growth may depend upon the ability to extend the longevity of results from facial injections, in order compete more strongly against cosmetic surgery. Still, the global botox market is forecast to reach $2.9 billion by 2018 at a CAGR of 14%. The entire global market for facial aesthetics is forecast to reach $4.7 billion in 2018, of which the US is expected to contribute over US$2 billion.

This report provides key data, information and analysis on the global facial aesthetics market. It gives the market landscape, competitive landscape and market trends information for the facial aesthetics market, and provides comprehensive information on the key trends affecting the market, as well as key analytical content. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData is a leading global business intelligence provider offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/ReportStore/Report.aspx?ID=Facial-Aesthetics-%28Botulinum-Toxin-Dermal-Fillers%29-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2018&companyID=sbwire

Visit our report store: http://www.globaldata.com/reportstore

For more details contact:
pressreleases@globaldata.com

North America:
+1 646 395 5477
Europe:
+44 207 753 4299
+44 1204 543 533
Asia Pacific:
+91 40 6616 6782